Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 36,009 | 37,579 | 38,698 | 33,580 | 36,145 |
| Cost of Goods | 911 | 1,194 | 1,351 | 1,868 | 980 |
| Gross Profit | 35,098 | 36,385 | 37,347 | 31,712 | 35,165 |
| Operating Expenses | 67,269 | 66,152 | 68,597 | 66,449 | 66,984 |
| Operating Income | -31,260 | -29,573 | -30,899 | -33,869 | -30,839 |
| Interest Expense | 6,073 | 5,784 | 5,758 | 5,885 | 6,114 |
| Other Income | 2,839 | 2,854 | 2,585 | 1,321 | 674 |
| Pre-tax Income | -34,494 | -32,503 | -34,072 | -38,433 | -36,279 |
| Income Tax | 12 | 127 | 54 | 73 | 45 |
| Net Income Continuous | -34,506 | -32,630 | -34,126 | -38,506 | -36,324 |
| Net Income | $-34,506 | $-32,630 | $-34,126 | $-38,506 | $-36,324 |
| EPS Basic Total Ops | -4.50 | -4.35 | -4.50 | -6.30 | -6.75 |
| EPS Basic Continuous Ops | -4.52 | -4.28 | -4.51 | -6.24 | -6.79 |
| EPS Diluted Total Ops | -4.50 | -4.35 | -4.50 | -6.30 | -6.75 |
| EPS Diluted Continuous Ops | -4.52 | -4.28 | -4.51 | -6.24 | -6.79 |
| EBITDA(a) | $-31,911 | $-30,314 | $-31,534 | $-34,010 | $-30,745 |